All companies
Visit website
REGENMED
OperatingRegenMed, Inc.
Healthcare · Founded 2014
Re-imagining and democratizing clinical research
Post-money valuation ⓘ
$20.3M
As of Oct 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$258,487
Across 2 rounds since 2024
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$63K
−$891K
2022
$97K
−$1.1M
2023
$281K
−$1.1M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$63,382
$96,500
$280,793
Cost of goods sold
$0
$0
$25,000
Gross margin
100%
100%
91%
Net income
-$890,958
-$1,093,806
-$1,075,117
Taxes paid
$0
$0
$0
Balance sheet
Cash
$99,203
$60,817
$36,268
Accounts receivable
$0
$0
$0
Total assets
$1,388,899
$1,265,684
$780,046
Short-term debt
$9,420
$0
$0
Long-term debt
$837,263
$1,615,000
$0
Total liabilities
$846,683
$1,615,000
$0
Other
Headcount
—
1
14
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$20.3M
post-money
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $4.7M
Raised $258.5K / $1.2MInvestors 38Post-money $20.3M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
38 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 12 filings on EDGARSource: ManualCIK 0002038981
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.